Literature DB >> 3053550

A40926 aglycone and pseudoaglycones: preparation and biological activity.

E Selva1, B P Goldstein, P Ferrari, R Pallanza, E Riva, M Berti, A Borghi, G Beretta, R Scotti, G Romanò.   

Abstract

A40926 antibiotics are new glycopeptides which are much more active than other members of this class against Neisseria gonorrhoeae. Their activity against Gram-positive bacteria, including coagulase-negative Staphylococci, is similar to that of other glycopeptides. An A40926 preparation containing factors A and B ("A40926 A + B complex") was hydrolyzed to the aglycone and to the mannosyl and N-acylaminoglucuronyl aglycones. The mannosyl aglycone and the aglycone were less active than A40926 A + B complex against Streptococci and Gram-positive anaerobes and lost the anti-gonorrheal activity. In contrast, the N-acylaminoglucuronyl aglycones were as active as the parent complex against these Gram-positive bacteria and were moderately active against N. gonorrhoeae. The aglycone and, even more so, the N-acylaminoglucuronyl aglycones, had better activity than the parent complex against coagulase-negative Staphylococci. In experimental septicemia in the mouse, A40926 A + B complex and its derivatives had activity proportional to their MIC for the test organism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053550     DOI: 10.7164/antibiotics.41.1243

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  1 in total

1.  Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic.

Authors:  B P Goldstein; G Candiani; T M Arain; G Romanò; I Ciciliato; M Berti; M Abbondi; R Scotti; M Mainini; F Ripamonti
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.